The Manufacturers Life Insurance Company Has $41.64 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

The Manufacturers Life Insurance Company decreased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 6.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 138,742 shares of the company's stock after selling 10,002 shares during the quarter. The Manufacturers Life Insurance Company owned 0.05% of HCA Healthcare worth $41,643,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Galvin Gaustad & Stein LLC bought a new position in HCA Healthcare in the fourth quarter worth about $18,044,000. NRI Wealth Management LC acquired a new stake in HCA Healthcare in the fourth quarter worth $2,896,000. Czech National Bank lifted its position in HCA Healthcare by 4.5% in the 4th quarter. Czech National Bank now owns 39,543 shares of the company's stock valued at $11,869,000 after purchasing an additional 1,691 shares during the last quarter. Peak Financial Advisors LLC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $1,122,000. Finally, Wedge Capital Management L L P NC boosted its position in HCA Healthcare by 7.7% during the 4th quarter. Wedge Capital Management L L P NC now owns 116,075 shares of the company's stock worth $34,840,000 after acquiring an additional 8,329 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

HCA Healthcare stock traded up $4.76 during trading hours on Tuesday, hitting $354.14. The stock had a trading volume of 262,632 shares, compared to its average volume of 1,393,360. The company has a market cap of $87.19 billion, a PE ratio of 16.11, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a 50-day moving average of $332.39 and a two-hundred day moving average of $329.21.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The firm's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the business earned $5.36 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.81%. HCA Healthcare's dividend payout ratio is currently 12.81%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on HCA shares. Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research note on Monday, January 27th. StockNews.com upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Barclays reduced their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research report on Monday, January 27th. Truist Financial decreased their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Finally, Guggenheim assumed coverage on HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating on the stock. One analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $381.13.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.